The Role of Platelet to Lymphocyte Ratio (PLR) in Predicting Early Treatment Response in Diffuse Large B Cell Lymphoma

Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24:679–690

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A et al (2014) An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the Rituximab era. Blood 123(6):837–842

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grivennikov SI, Greten FR, Karin M (2010) Immunity, infammation, and cancer. Cell 140(6):883–899

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni J, Wang YQ, Zhang YP, Wu W, Zeng QS, Yang MZ et al (2016) Value of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for prognostic evaluation of difuse large B-cell lymphoma. J Exp Hematol 24(2):427–432

Google Scholar 

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88(1):218–230

Article  PubMed  Google Scholar 

Zhang M, Huang XZ, Song YX, Gao P, Sun JX, Wang ZN (2017) High platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with breast Cancer: a Meta-analysis. Biomed Res Int 2017:9503025

Article  PubMed  PubMed Central  Google Scholar 

Takenaka Y, Oya R, Kitamiura T, Ashida N, Shimizu K, Takemura K et al (2018) Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis. Head Neck 40(12):2714–2723

Article  PubMed  Google Scholar 

Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W et al (2018) Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. Br J Haematol 180(4):545–549

Article  CAS  PubMed  Google Scholar 

Keam B, Ha H, Kim TM, Jeon YK, Lee SH, Kim DW et al (2015) Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma 56(7):2032–2038

Article  CAS  PubMed  Google Scholar 

Hu H, Yao X, Xie X, Wu X, Zheng C, Xia W et al (2017) Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol 35(2):261–270

Article  CAS  PubMed  Google Scholar 

Wang S, Ma Y, Sun L, Shi Y, Jiang S, Yu K et al (2018) Prognostic Significance of Pretreatment Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in patients with diffuse large B-Cell lymphoma. Biomed Res Int 2018:9651254

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Zhang Z, Fang Q, Jian H (2019) Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis. Cancer Cell Int 19:245

Article  PubMed  PubMed Central  Google Scholar 

Xu H, Zheng X, Ai J, Yang L (2023) Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol 114:109496

Article  CAS  PubMed  Google Scholar 

El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY (2018) FDG-PET/CT in the management of lymphomas: current status and future directions. J Intern Med 284(4):358–376

Article  CAS  PubMed  Google Scholar 

Ma Z, Niu J, Cao Y, Pang X, Cui W, Zhang W et al (2020) Clinical significance of ‘double-hit’ and ‘double-expression’ lymphomas. J Clin Pathol 73(3):126–138

Article  CAS  PubMed  Google Scholar 

Yoo KH (2022) Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT. Blood Res 57(S1):75–78

Article  PubMed  PubMed Central  Google Scholar 

McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226

Article  PubMed  Google Scholar 

Mizunuma M, Yokoyama Y, Futagami M, Aoki M, Takai Y, Mizunuma H (2015) The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Int J Clin Oncol 20(5):989–996

Article  CAS  PubMed  Google Scholar 

Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T et al (2008) Predominant infiltration of macrophages and CD8(+) T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 113(6):1387–1395

Article  CAS  PubMed  Google Scholar 

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y et al (2008) Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients’ survival benefit from Rituximab. Eur J Haematol 81(6):448–453

Article  PubMed  Google Scholar 

Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G et al (2008) Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma. Leuk Lymphoma 49(9):1745–1751

Article  PubMed  Google Scholar 

Masucci MT, Minopoli M, Carriero MV (2019) Tumor Associated neutrophils. Their role in Tumorigenesis, Metastasis, Prognosis and Therapy. Front Oncol 9:1146

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Zhou X, Liu Y, Li Z, Li X (2017) Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: a meta-analysis. PLoS ONE 12(4):e0176008

Article  PubMed  PubMed Central  Google Scholar 

Mu S, Ai L, Fan F, Qin Y, Sun C, Hu Y (2018) Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis. Cancer Cell Int 18:119

Article  PubMed  PubMed Central  Google Scholar 

Vlatka P, Marko L, Stefan M, Dorian L (2022) The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel prognostic factor for patients with diffuse large B-cell lymphoma. J Cancer Res Ther 18(3):725–732

Article  CAS  PubMed  Google Scholar 

Saglam B, Albayrak M, Yıldız A, Tığlıoğlu P, Tığlıoğlu M, Aras MR et al (2023) The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma. Niger J Clin Pract 26(10):1512–1518

Article  CAS  PubMed  Google Scholar 

Wei L, Gao Y, Prochazka KT, Liu R, Wang L, Liu B et al (2023) A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study. J Neurooncol 163(2):301–311

Article  CAS  PubMed  Google Scholar 

Schlesinger M (2018) Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol 11(1):125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye X et al (2015) Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol 36(12):9319–9325

Article  CAS  PubMed  Google Scholar 

Tao Y, He X, Qin Y, Liu P, Zhou S, Yang J et al (2021) Low platelet/platelet distribution width and high platelet/lymphocyte ratio are adverse prognostic factors in patients with newly diagnosed advanced Hodgkin lymphoma. Leuk Lymphoma 62(13):3119–3129

Article  CAS  PubMed 

留言 (0)

沒有登入
gif